NCT07726875

Brief Summary

To explore the relationship between plasma orexin levels during the recovery period of elderly patients undergoing general anesthesia and the occurrence of emergence delirium, and to evaluate its sensitivity and specificity as an objective diagnostic indicator for emergence delirium

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Mar 2026Feb 2027

Study Start

First participant enrolled

March 31, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2027

Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

10 months

First QC Date

July 21, 2026

Last Update Submit

July 21, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Emergece Delirium

    During extubation and 20 minutes after extubation

  • Plasma Orexin

    During extubation and 20 minutes after extubation

Secondary Outcomes (1)

  • Postoperative delirium

    5 days post- operation

Study Arms (2)

Emergence delirium group

Other: No Intervention: Observational Cohort

Non-Emergence delirium group

Other: No Intervention: Observational Cohort

Interventions

No Intervention: Observational Cohort

Emergence delirium groupNon-Emergence delirium group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

elderly patients undergoing general anesthesia

You may qualify if:

  • Age is greater than or equal to 60 years old
  • It is planned to undergo elective non-cardiac surgery under general anesthesia, with the expected operation duration being greater than or equal to 2 hours
  • ASA I-III

You may not qualify if:

  • There was a clear diagnosis of mental illness before the surgery (such as schizophrenia, severe depression, etc.) or the patient had been using antidepressants or anti-psychotic drugs for a long time.
  • Preoperative presence of sleep-wake disorder-related diseases (such as narcolepsy, untreated moderate to severe obstructive sleep apnea syndrome, etc.) or long-term use of orexin receptor antagonists or agonists
  • Preoperatively, there was severe liver dysfunction (Child-Pugh grade B or C), severe renal dysfunction (estimated glomerular filtration rate eGFR \< 30 ml/min/1.73㎡), and severe anemia (Hb \< 80 g/L)
  • Perform deep sedation for extubation, plan to transfer to the ICU, or experience severe complications during the recovery period (such as anaphylactic shock, laryngospasm, etc.)
  • There are cases where individuals have severe visual or hearing impairments, or are aphasic, and thus are unable to cooperate in completing the cognitive assessment.
  • Having a history of alcohol abuse or drug addiction
  • Emergency surgery, neurosurgery surgery
  • The researchers considered it inappropriate to include in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 24, 2026

Study Start

March 31, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

February 5, 2027

Last Updated

July 24, 2026

Record last verified: 2026-07

Locations